BrioHealth Solutions
Farzad Parsaie possesses extensive experience in quality assurance, regulatory affairs, and program management within the healthcare and medical device industries. Currently serving as Senior Director of Quality Assurance & Quality Systems at BrioHealth Solutions, Farzad has previously held key positions including Vice President of Quality Assurance & Regulatory Affairs at SpectraWAVE, Inc., and Senior Program Manager roles at both Johnson & Johnson and Verb Surgical Inc. In addition, Farzad is the former President & CEO of Nido Surgical, bringing a strong leadership background to the various roles within the R&D and surgical robotics sectors.
This person is not in any teams
This person is not in any offices
BrioHealth Solutions
1 followers
About BrioHealth Solutions We are a global team of like-minded Med-Tech professionals focused on patient centric solutions in a collaborative environment leading to excellent outcomes. We have developed an advanced and unique heart failure therapy technology in the BrioVAD® Left Ventricular Assist System (LVAS). We are introducing the BrioVAD LVAS to Heart Failure clinicians for use with the large number of indicated and untreated patients who could benefit from chronic mechanical circulatory support. The initiation of our INNOVATE™ Trial in the US is only the beginning. We are building a team to develop advanced technology intended to further improve patient outcomes, increase therapy acceptance, and enabling chronic MCS therapy to be accessible to more patients across the globe. About the BrioVAD® Left Ventricular Assist System (LVAS)* Leveraging innovative pump design with long-blade rotor technology, the BrioVAD® LVAS has been designed to create an optimal blood flow path, boosting cardiac output, while minimizing complications. BrioVAD® LVAS’s patient-centric design enhances patient comfort and promotes a sense of vitality and improved well-being. *The BrioVAD® LVAS is an Investigational Device and limited by Federal law to investigational use.